Comments on: Big Pharmaceutical Companies Making Cautious Plays for Facebook Users

By: Facebook Forces Drug Companies to Open Walls

Facebook Forces Drug Companies to Open Walls — Mon, 15 Aug 2011 17:32:35 +0000

[...] drug companies. (Our sister site, Inside Facebook, gives some valuable background on the issue by explaining why drug companies were slow to engage on social [...]

By: Kris Subramanian

Kris Subramanian — Fri, 22 Oct 2010 15:49:10 +0000

Pharma spends billions into making a medicine, goes through the clinical trials and waits for almost 10 years to get their drug approved. True that pharma does all this for money, but without their efforts a cancer curing or alzheimers curing drug is not going to come out in the market on its own. So now after spending billions, they will seek all methods to sell it to recover their money.

By: saurabh singh

saurabh singh — Tue, 17 Aug 2010 11:25:18 +0000

i m pass out m.sc biotech

By: josh

josh — Fri, 05 Mar 2010 13:27:25 +0000

Awesome post.
Another web time, time for me to go and get some offers out there.
Cheers

By: Knowledge Management in Pharma Conference. Part 2 of 2. | Gil Yehuda's Enterprise 2.0 Blog

Thu, 18 Feb 2010 20:02:21 +0000

[...] forums, e.g. Facebook, patient advocacy groups, or their own white-label social networks (see here for some examples). This is a really complex issue – and for many of the reasons that KM is [...]

By: Pharma’s Facebook Future Still Murky – Heartbeat Digital: The Pulse

Pharma’s Facebook Future Still Murky – Heartbeat Digital: The Pulse — Wed, 10 Feb 2010 18:24:31 +0000

[...] http://www.insidefacebook.com/2010/02/08/big-pharmaceutical [...]

By: Robert Rooney

Robert Rooney — Wed, 10 Feb 2010 10:54:59 +0000

Pharma has constantly shown that it will abuse any trust put in it by patients. Recent surveys (http://patientscorner.posterous.com/) only confirm pharma’s dwindling reputation in this regard. The information deficit will not be met by pharma marketeers but by even stronger regulation restraining their spoofery combined with more active support from public health authorities working in partnership with empowered patient groups to get relevant information to patients when and where they need it. It’s so sad to see patients signed up to these biased (e.g UCB) information or disease awareness pages and is an indictment of the lack of quality information out there which pharma is only too willing to exploit to push its treatments. FDA when are you going to stop being swayed by the lobby of Marketeers egged on by an army of Health2.0 consultants who would have us believe the propoganda that patients actually want an online relationship with their treatments in the name of more expensive facebook apps, fancier websites, higher health2.0 consulting fees and ultimately..higher drug prices. Please start to take the patients views into account before enacting any new regulation.

By: PBM Consulting

PBM Consulting — Tue, 09 Feb 2010 21:18:35 +0000

This is a result of too many regulations. We keep seeing problems rise in medicine for advertising. If they are restricted from the mainstream, they are forced to find alternative solutions.